Successful treatment of concurrent cold agglutinin disease and myelodysplastic syndrome

Transfus Apher Sci. 2024 Jun;63(3):103939. doi: 10.1016/j.transci.2024.103939. Epub 2024 Apr 25.

Abstract

Herein, we describe a case of severe anemia presenting with myelodysplastic syndrome with cold agglutinin disease that was successfully treated by a moderate dose of steroids followed by cyclosporine. In patients with myelodysplastic syndrome, autoimmunity in erythroid cells is occasionally demonstrated, and autoimmune hemolytic anemia is seen in some patients. However, hemolytic anemia with cold agglutinin in patients with myelodysplastic syndrome is less common, and the effect of corticosteroids for autoimmune hemolytic anemia caused by cold agglutinin is thought to be limited. Although the elevated levels of reticulocytes and LDH are usually caused by ineffective hematopoiesis in myelodysplastic syndrome, clinicians should be aware of latent cold agglutinin disease. In the present case, in addition to the improvement of erythroid dysplasia, the corticosteroid-sparing effect on cold agglutinin disease may have played a role in the mechanism underlying the effectiveness of cyclosporine.

Keywords: Cold agglutinin disease; Corticosteroid; Cyclosporine; Myelodysplastic syndrome.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anemia, Hemolytic, Autoimmune* / drug therapy
  • Cyclosporine / therapeutic use
  • Female
  • Humans
  • Myelodysplastic Syndromes* / complications
  • Myelodysplastic Syndromes* / therapy